STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CHE CHEMED CORPORATION StockScouter® Report

8

StockScouter® Score

CHEMED CORPORATION, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • The 50-day moving average for CHE is significantly above its 200-day moving average. Positive
  • One or more less experienced analysts has modestly increased quarterly earnings estimates for CHE. Positive/Neutral

 

Concerns

  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

B
C
C
A

Previous Ratings

6
7
9